Innovative drug Tarceva® now available in Europe to tackle growing lung cancer epidemic
Lung cancer has become a global epidemic with 1.2 million people being diagnosed and 1.1 million people dying each year. There have been no significant improvements in the effectiveness of chemotherapy agents in the last ten years so new therapies, that can improve survival, are urgently needed.
Come and hear eminent experts in the field of lung cancer including, specialists, patient groups and patients themselves, discuss the economic impact and access to lung cancer care, the patient experience and Tarceva® an unprecedented improvement in the treatment of advanced lung cancer.
Professor Nick Thatcher
CRC Department of Medical Oncology
Dr. Jesme Baird
Global Lung Cancer Coalition and Director of Patient Care, Roy Castle Lung Cancer
Foundation, Glasgow, UK
Professor Giuseppe Giaccone
VU Medical Center, Amsterdam
Professor Bengt Jönsson, Ph.D
Professor in Health Economics, Stockholm
School of Economics and the Karolinska
Monday, 31 October 2005 08:30 CET
Room 243, Level 2 Palais des Congrès de Paris
2, Place de la Porte Maillot
75017 Paris, France
MEDIA CONTACT AT ECCO CONGRESS:
Anthea Morris Resolute Communications
Helen Bridges Resolute Communications
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.